Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Immunotoxin Containing a Disulfide-Stablized Antibody Fragment Joined to a Pseudomonas Exotoxin That Does Not Require Proteolytic Activation

  • Read more about Immunotoxin Containing a Disulfide-Stablized Antibody Fragment Joined to a Pseudomonas Exotoxin That Does Not Require Proteolytic Activation
US Patent 5,980,895
Filed on 1997-08-21

RECOMBINANT RIBONUCLEASE PROTEINS

  • Read more about RECOMBINANT RIBONUCLEASE PROTEINS
US Patent 6,045,793
Filed on 1998-02-19

Method of Treating Inflammation with Antibodies to Neutrophil Chemotactic Factor (As Amended).

  • Read more about Method of Treating Inflammation with Antibodies to Neutrophil Chemotactic Factor (As Amended).
US Patent 5,925,352
Filed on 1997-09-23

8-CI Camp as Anti-Cancer Drug

  • Read more about 8-CI Camp as Anti-Cancer Drug
US Patent 5,902,794
Filed on 1997-09-22

ISOLATION OF ESSENTIAL BACTERIAL GENES, DETECTION OF BACTERIAL SPECIES AND DEVELOPMENT OF ANTIMICROBIAL AGENTS BASED ON STRUCTURE AND...

  • Read more about ISOLATION OF ESSENTIAL BACTERIAL GENES, DETECTION OF BACTERIAL SPECIES AND DEVELOPMENT OF ANTIMICROBIAL AGENTS BASED ON STRUCTURE AND...
US Patent 6,132,954
Filed on 1997-08-20

O2-ARYLATED OR O2-GLYCOSYLATED 1-SUBSTITUTED DIAZEN-1-IUM-1,2-DIOLATES AND O2-SUBSTITUTED 1-[(2-CARBOXYLATO)PYRROLIDIN-1-YL]DIAZEN-1-IUM ...

  • Read more about O2-ARYLATED OR O2-GLYCOSYLATED 1-SUBSTITUTED DIAZEN-1-IUM-1,2-DIOLATES AND O2-SUBSTITUTED 1-[(2-CARBOXYLATO)PYRROLIDIN-1-YL]DIAZEN-1-IUM ...
Patent Cooperation Treaty
PCT/US1997/017267
Filed on 1997-09-26

METHODS OF IDENTIFYING PATIENTS HAVING AN ALTERED IMMUNE STATUS

  • Read more about METHODS OF IDENTIFYING PATIENTS HAVING AN ALTERED IMMUNE STATUS
US Patent 5,658,744
Filed on 1994-07-22

EVALUATION AND TREATMENT OF PATIENTS WITH PROGRESSIVE IMMUNOSUPPRESSION

  • Read more about EVALUATION AND TREATMENT OF PATIENTS WITH PROGRESSIVE IMMUNOSUPPRESSION
US Patent 5,889,143
Filed on 1996-09-16

SHORT-TERM ANTI-CD3 STIMULATION OF LYMPHOCYTES TO INCREASE THEIR IN VIVO ACTIVITY

  • Read more about SHORT-TERM ANTI-CD3 STIMULATION OF LYMPHOCYTES TO INCREASE THEIR IN VIVO ACTIVITY
US Application 08/251,860
Filed on 1994-05-31

EVALUATION AND TREATMENT OF PATIENTS WITH PROGRESSIVE IMMUNOSUPPRESSION

  • Read more about EVALUATION AND TREATMENT OF PATIENTS WITH PROGRESSIVE IMMUNOSUPPRESSION
US Patent 5,556,763
Filed on 1993-03-17

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1540
  • Page 1541
  • Page 1542
  • Page 1543
  • Page 1544
  • Page 1545
  • Page 1546
  • Page 1547
  • Page 1548
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health